KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Retained Earnings: 2014-2025

Historic Retained Earnings for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Sep 2025 value amounting to -$860.2 million.

  • Aurinia Pharmaceuticals' Retained Earnings rose 8.30% to -$860.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$860.2 million, marking a year-over-year increase of 8.30%. This contributed to the annual value of -$936.6 million for FY2024, which is 0.61% up from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Retained Earnings stood at -$860.2 million for Q3 2025, which was up 3.54% from -$891.7 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Retained Earnings high stood at -$625.5 million for Q1 2021, and its period low was -$953.1 million during Q1 2024.
  • Over the past 3 years, Aurinia Pharmaceuticals' median Retained Earnings value was -$915.4 million (recorded in 2023), while the average stood at -$917.8 million.
  • In the last 5 years, Aurinia Pharmaceuticals' Retained Earnings plummeted by 89,688.82% in 2021 and then grew by 8.30% in 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Retained Earnings (Quarterly) stood at -$756.1 million in 2021, then fell by 14.31% to -$864.3 million in 2022, then dropped by 9.03% to -$942.3 million in 2023, then rose by 0.61% to -$936.6 million in 2024, then climbed by 8.30% to -$860.2 million in 2025.
  • Its Retained Earnings stands at -$860.2 million for Q3 2025, versus -$891.7 million for Q2 2025 and -$913.2 million for Q1 2025.